Theranostics
Overview
Theranostics is a leading interdisciplinary journal that focuses on the integration of diagnostics and therapeutics in medicine. It publishes cutting-edge research articles, reviews, and commentaries, covering a wide range of topics including molecular imaging, targeted therapy, nanomedicine, and personalized medicine. With its emphasis on translational research, Theranostics aims to advance the field of theranostics and facilitate the development of innovative diagnostic and therapeutic strategies for improved patient care.
Details
Details
Metrics
Metrics
h-index / Ranks: 1275
158
SJR / Ranks: 633
2912
CiteScore / Ranks: 315
20.90
JIF / Ranks: 313
12.4
Recent Articles
1.
Ma X, Zhu X, Lv S, Yang C, Wang Z, Liao M, et al.
Theranostics
. 2025 Mar;
15(7):2933-2950.
PMID: 40083946
The timely management of large-scale wounds and the regeneration of skin appendages constitute major clinical issues. The production of high-precision and customizable artificial skin via 3D bioprinting offers a feasible...
2.
Hu T, Meng S, Liu C, Fang W, Xia Z, Hu Y, et al.
Theranostics
. 2025 Mar;
15(7):2967-2990.
PMID: 40083945
Acute high intraocular pressure (IOP) induces retinal ischemia/reperfusion (RI/R) that further initiates neuroinflammatory responses. This event can cause retinal tissue damage and neuronal death, ultimately resulting in irreversible blindness worldwide...
3.
Vichare R, Janjic J
Theranostics
. 2025 Mar;
15(7):3013-3034.
PMID: 40083944
Perfluorocarbons (PFCs) are formulated into kinetically stable nanoemulsions (NEs) having a droplet diameter less than 500 nm for biomedical applications. PFC NEs are developed for various applications, such as F...
4.
Wu X, Fei W, Shen T, Ye L, Li C, Chu S, et al.
Theranostics
. 2025 Mar;
15(7):2903-2932.
PMID: 40083943
Mechanical force transmission is pivotal in tumor biology, profoundly affecting cancer cell behaviors such as proliferation, metastasis, and resistance to therapy. To explore novel biomechanical-based therapeutic strategies for cancer treatment,...
5.
Cheng G, Chang J, Ke S, Dai Z, Gong D, Gong H, et al.
Theranostics
. 2025 Mar;
15(7):2951-2966.
PMID: 40083942
Organelles in neuronal dendrites facilitate local metabolic processes and energy supply, crucial for dendrite development and neurodegenerative diseases. The distinct functions of dendritic organelles have been well studied, however, their...
6.
Lin Y, Lin P, Xu R, Chen X, Lu Y, Zheng J, et al.
Theranostics
. 2025 Mar;
15(7):3098-3121.
PMID: 40083941
Cancer immunotherapy leveraging nanovaccines represents a cutting-edge frontier in precision medicine, specifically designed to potentiate CD8 T cell-based immunotherapy. This review thoroughly delineates the evolving landscape of cancer nanovaccine development,...
7.
Zhu X, Wang S, Xue Y, Wang X, Hu S, Liang T, et al.
Theranostics
. 2025 Mar;
15(7):2870-2882.
PMID: 40083940
Significant efforts and resources have been dedicated to developing CRISPR-Cas based point-of-care testing (POCT) and self-diagnosis methods for nucleic acid pathogens, aiming to complement the gold standard quantitative PCR tests,...
8.
Olmedo-Moreno L, Panadero-Moron C, Sierra-Parraga J, Bueno-Fernandez R, Norton E, Aguilera Y, et al.
Theranostics
. 2025 Mar;
15(7):3076-3097.
PMID: 40083939
Glioblastoma (GBM) is the most fatal form of brain cancer and its treatment represents a persistent challenge. Mesenchymal stromal cells (MSCs) have been explored as therapeutic tools in cancer management...
9.
Lee J, Na Y, Na C, Im P, Park H, Kim M, et al.
Theranostics
. 2025 Mar;
15(7):2883-2902.
PMID: 40083938
Superparamagnetic iron oxide nanoparticles (SPIONs) are promising contrast agents for imaging-guided cancer therapies. However, challenges such as the requirement for a high alternating magnetic field (AMF), dosage limitations, and suboptimal...
10.
Sun M, Ren W, Zhao Y, Li X, Khan M, Cheng X, et al.
Theranostics
. 2025 Mar;
15(7):3159-3184.
PMID: 40083937
Cognitive impairment and depression are salient comorbidities of mesial temporal lobe epilepsy; it is still unclear whether this frequently drug resistant disease is a cause or consequence of hippocampal damage...